|
Market Closed -
Nasdaq
16:00:00 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 55.95 USD | -1.20% |
|
+2.32% | -5.86% |
| Market Cap | 10.83B 9.67B 8.93B 8.1B 15.15B 1,028B 15.4B 108B 42.57B 539B 40.65B 39.78B 1,698B | P/E 2026 * |
30.5x | P/E 2027 * | 11.7x |
|---|---|---|---|---|---|
| Enterprise Value | 13.21B 11.79B 10.89B 9.87B 18.47B 1,254B 18.78B 131B 51.9B 657B 49.56B 48.51B 2,071B | EV / Sales 2026 * |
3.37x | EV / Sales 2027 * | 2.74x |
| Free-Float |
99.66% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BMRN | Delayed | |
CBOE
| BMRN | Real-time | |
|
London S.E.
| 0HNC | Delayed | |
|
Mexican S.E.
| BMRN * | End-of-day quote | |
|
Deutsche Boerse AG
| BM8 | Delayed | |
|
Berne S.E.
| BM8 | End-of-day quote | |
|
Tradegate
| BM8 | Real-time | |
|
Wiener Boerse
| BMRN | End-of-day quote | |
|
Börse Stuttgart
| BM8 | Delayed | |
|
Boerse Muenchen
| BM8 | Real-time | |
|
Borsa Italiana
| 1BMRN | End-of-day quote |
Last Transcript: BioMarin Pharmaceutical Inc.
| 1 day | -1.20% | ||
| 1 week | +2.32% | ||
| Current month | -6.75% | ||
| 1 month | -8.80% | ||
| 3 months | -5.70% | ||
| 6 months | +5.21% | ||
| Current year | -5.86% |
| 1 week | 54.08 |  | 57 |
| 1 month | 53.9 | | 60.7 |
| Current year | 49.26 | | 70.98 |
| 1 year | 49.26 | | 70.98 |
| 3 years | 49.26 | | 99.56 |
| 5 years | 49.26 | | 117.77 |
| 10 years | 49.26 | | 131.94 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alexander Hardy
CEO | Chief Executive Officer | 57 | 2023-11-30 |
Brian Mueller
DFI | Director of Finance/CFO | 52 | 2020-01-28 |
Arpit Davé
CTO | Chief Tech/Sci/R&D Officer | - | 2026-01-11 |
| Director | Title | Age | Since |
|---|---|---|---|
Willard Dere
BRD | Director/Board Member | 72 | 2016-07-17 |
Robert Hombach
BRD | Director/Board Member | 60 | 2017-09-28 |
| Director/Board Member | 69 | 2019-07-09 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/30/26 | Tax | Chief Technology Officer | -4,086 | 0.0021% | ||
| 9/10/26 | Free | Director | 6,140 | 0.0032% | ||
| 9/2/26 | Sell | General Counsel | -17,557 | 0.0091% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.20% | +2.32% | +2.70% | -32.87% | 10.83B | |
| -2.54% | +1.31% | +54.27% | +114.96% | 1,135B | |
| -1.42% | +3.23% | +38.56% | +74.44% | 635B | |
| +0.16% | +0.08% | +25.29% | +95.23% | 505B | |
| -0.31% | +3.09% | +44.14% | +64.80% | 378B | |
| -1.34% | -0.47% | +66.04% | +41.00% | 358B | |
| -0.68% | +2.65% | +22.98% | +50.39% | 295B | |
| -1.20% | +3.04% | +2.33% | +22.86% | 266B | |
| -1.79% | +1.57% | +50.56% | +59.08% | 237B | |
| -0.73% | -0.10% | +29.02% | +99.67% | 193B | |
| Average | -1.10% | +2.05% | +33.59% | +58.96% | 401.45B | |
| Weighted average by Cap. | -1.35% | +2.66% | +40.92% | +79.45% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.92B 3.5B 3.24B 2.93B 5.49B 372B 5.58B 38.94B 15.42B 195B 14.72B 14.41B 615B | 4.5B 4.02B 3.72B 3.37B 6.3B 428B 6.4B 44.71B 17.7B 224B 16.9B 16.54B 706B |
| Net income | 327M 292M 270M 245M 458M 31.06B 465M 3.25B 1.29B 16.27B 1.23B 1.2B 51.3B | 942M 841M 777M 704M 1.32B 89.44B 1.34B 9.35B 3.7B 46.86B 3.54B 3.46B 148B |
| Net Debt | 2.38B 2.12B 1.96B 1.78B 3.32B 226B 3.38B 23.59B 9.34B 118B 8.92B 8.73B 373B | 1.51B 1.35B 1.25B 1.13B 2.12B 144B 2.15B 15.02B 5.95B 75.26B 5.68B 5.56B 237B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-23 | US$55.95 | -1.20% | 1,682,821 |
| 26-10-22 | US$56.63 | +2.57% | 2,396,857 |
| 26-10-21 | US$55.21 | -2.18% | 2,506,314 |
| 26-10-20 | US$56.44 | +3.24% | 3,474,620 |
| 26-10-19 | US$54.67 | -0.02% | 2,995,697 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BMRN Stock
Select your edition
All financial news and data tailored to specific country editions
